investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
MicroRNA-125b physiologically and pathologically regulates myelopoiesis through I
Arnav Mehta
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Arnav Mehta
California Institute of Technology
Pasadena, United States
Related projects
Scott W Lowe
The impact of chromosome 17p lesions on leukemogeneis and therapy response
Leukaemia
Pathology
Hematology and hematologic malignancies
Clark W Distelhorst
Bcl-2 Function on the Endoplasmic Reticulum
Leukaemia
Pathology
Hematology and hematologic malignancies
Hao Yuan Kueh
Single cell analysis of hematopoietic cell fate determination
Leukaemia
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Michael R Green
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
Leukaemia
Pathology
Hematology and hematologic malignancies
Markus Muschen
Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia
Leukaemia
Kapil Bhalla
Novel Targeted Therapy for AML
Leukaemia
Ross L Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
Leukaemia
Xuefang Cao
Targeting Granzyme B to Separate GVH from GVL Responses
Leukaemia